Articles tagged "Economics"

2019 American Transplant Congress
Do Reimbursement Programs Increase The Number Of Living Organ Donations?
A. Siddique¹, J. Ortiz², S. Fry-Revere², V. Apte², Y. Jin³, N. Koizumi¹
¹Schar School of Policy and Government, George Mason University, Arlington, VA, ²University of Toledo Hospital, Toledo, OH, ³The State University of New Jersey, New Brunswick, NJ
*Purpose: Living-donor kidney transplantation is the gold standard treatment for the end-stage renal disease. However, living donors worldwide face significant financial and logistic barriers. To…
2019 American Transplant Congress
Racial and Income-Based Disparities in Access to Kidney Transplantation in the Context of a Nationally-Financed Health System in Brazil
A. Saha¹, G. Ferreira², Y. Yu¹, M. Waldram¹, V. Colares², J. Bastos², M. Henderson¹, D. Segev¹, A. Massie¹
¹Surgery, Johns Hopkins School of Medicine, Baltimore, MD, ²Santa Casa de Misericordia de Juiz de Fora, Juiz de Fora, Brazil
*Purpose: Changes in economic and social factors in low- and middle-income countries have led to rising burden of chronic disease. Brazil, a middle-income country with…
2019 American Transplant Congress
Lower Alcohol Taxes Are Associated with Increased Liver Transplant Listing
N. T. Shen¹, M. Raver¹, N. Hutchison¹, A. Jesudian¹, J. Bray², B. Schackman³, R. S. Brown¹
¹Medicine; Division of Gastroenterology and Hepatology, New York Presbyterian Hospital - Weill Cornell, New York, NY, ²Economics, University of North Carolina at Greensboro, Greensboro, NC, Greensboro, NC, ³Healthcare Policy and Research, Weill Cornell Medicine, New York, NY
*Purpose: Alcoholic liver disease (ALD) is a leading indication for liver transplantation worldwide with rising prevalence. Whether relationships exist between transplant listing for ALD and…
2019 American Transplant Congress
simplifyKDPI: An Animated Video to Educate Kidney Transplant Candidates about the Kidney Donor Profile Index
K. Bonner, R. Seibert, L. Kayler
SUNY Buffalo/ECMC, Buffalo, NY
*Purpose: simplifyKDPI is an iteratively-designed patient-engaged mobile educational animated video program developed with guidance from patients, providers and Self-efficacy and Multimedia Learning Theories to increase…
2019 American Transplant Congress
Organ Procurement Organization Performance is Not Related to Educational Spending
J. P. Roberts¹, J. Bragg-Gresham², P. Held³
¹Univ of California-San Francisco, San Francisco, CA, ²Nephrology, University of Michigan, Ann Arbor, MI, ³Stanford University, Stanford, CA
*Purpose: We examined the educational spending by OPOs in relationship to OPO performance metrics.*Methods: Data sources: OPO Cost Reports (CMS 216-94 Form), SRTR OPO Specific…
2018 American Transplant Congress
Cost Effectiveness of Lifelong Medicare Immunosuppressant Drug Coverage for Kidney Transplant Recipients in the Current Era
M. Kadatz,¹ J. Gill,² J. Gill,² K. Scott.³
¹Clinician Investigator Program, University of British Columbia, Vancouver, BC, Canada; ²Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada; ³Division of Nephrology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
While there is no Medicare time limit for dialysis patients, kidney transplant recipients lose their Medicare coverage 36 months after they receive their transplant. The…
2018 American Transplant Congress
Treatment Patterns and Burden among Chronic Graft versus Host Disease Patients on Second-Line Systemic Treatments Including Extracorporeal Photopheresis
X. Huang,² N. Joshi,¹ L. Luo,¹ G. Mitri,³ B. Lovelace,² A. Pham,³ X. Gao.¹
¹Pharmerit International, Bethesda, MD; ²Mallinckrodt Pharmaceuticals, Bedminster, NJ; ³Formerly of Mallinckrodt Pharmaceuticals, Bedminster, NJ.
Extracorporeal Photopheresis (ECP) is a cell-based immunomodulatory therapeutic procedure reimbursable by the Centers for Medicare and Medicaid Services for patients with chronic Graft versus Host…
2018 American Transplant Congress
The Living Donor Lost Wages Trial: Study Rationale, Protocol, and Update
J. Rodrigue,¹ M. Pavlakis,¹ A. Evenson,¹ A. Fleishman,¹ M. Carroll,¹ D. Mandelbrot,² P. Baliga,³ D. Howard,⁴ J. Schold.⁵
¹Beth Israel Deaconess Medical Center, Boston, MA; ²University of Wisconsin, Madison, WI; ³Medical University of South Carolina, Charleston, SC; ⁴Emory University, Atlanta, GA; ⁵Cleveland Clinic, Cleveland, OH.
Living donor kidney transplantation (LDKT) is the optimal treatment for adults with renal failure. However, living kidney donation has declined in the past decade, particularly…
2018 American Transplant Congress
Evaluation of Financial Well-Being of Living Kidney Donor Candidates
S. Singh,^1,2 G. Bannerman,² A. Yantsis,² M. Liu,² F. Gumabay,² O. Famure.²
¹Division of Nephrology, Department of Medicine, University of Toronto, Toronto, ON, Canada; ²Division of Nephrology and the Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
Despite the known benefits of living donor kidney transplantation, the rate of living kidney donation in Canada has not increased. Potential reasons include the lack…
2018 American Transplant Congress
Cost Impacts of Alternative Kidney Transplant Immunosuppression: A National Cohort Study
K. Lentine,¹ D. Axelrod,² V. Dharnidharka,³ H. Xiao,¹ D. Brennan,⁴ D. Segev,⁴ H. Randall,¹ R. Ouseph,¹ A. Naik,⁵ N. Lam,⁶ T. Alhamad,³ B. Kasiske,⁷ G. Hess,⁸ M. Schnitzler.¹
¹Saint Louis Univ, St. Louis; ²Lahey Clinic, Burlington; ³Washington Univ, St. Louis; ⁴Johns Hopkins, Baltimore; ⁵Univ Michigan, Ann Arbor; ⁶Univ Alberta, Edmonton, Canada; ⁷Hennepin County, Minneapolis; ⁸Symphony Health, Conshohocken.
Economic outcomes are increasingly considered along with clinical efficacy to guide choice of alternative therapies. We examined the cost impact of kidney transplant (KTx) induction…

« Previous Page
1
…
8
9
10
11
12
…
19
Next Page »